Abstract
Hypervirulent Klebsiella pneumoniae strains are typically associated with severe infections and susceptible to most antimicrobial agents. In 2017, a carbapenem-resistant hypervirulent K. pneumoniae (CR-hvKP) strain was isolated from the sputum of a chronic obstructive pulmonary disease (COPD) patient in Zhejiang, China. The goal of the present study was to characterize the molecular features of the CR-hvKP isolate ZJ27003 and its blaKPC-2-harboring plasmid p27003_KPC. Antimicrobial susceptibility was evaluated using the broth microdilution and agar dilution methods. String tests, serum-killing and mouse survival assays were performed to assess virulence, and plasmid conjugation was performed by filter mating. The complete genome sequence of ZJ27003 was acquired using a hybrid assembly of Illumina and Nanopore platform data. The sequence type (ST) of this CR-hvKP isolate was identified as ST23, which exhibits hypervirulence with high serum resistance and murine infection model. The strain is also resistant to carbapenems (imipenem, meropenem and ertapenem), aztreonam and cephalosporins. Additionally, the CR-hvKP isolate carries a 36,708-bp blaKPC-2-harboring plasmid, named p27003_KPC, belonging to the P1 incompatibility (Inc) group. The backbone of p27003_KPC is similar to that of a blaGES-5-harboring Pseudomonas aeruginosa plasmid, in which the blaGES-5 and its surrounding regions were replaced by a blaKPC-2-containing translocatable unit derived from Enterobacteriaceae. The results of a conjugation assay revealed that p27003_KPC can be transferred from K. pneumoniae to P. aeruginosa PAO1 and make the recipient resistant against carbapenem. The identification of a carbapenem-resistant hypervirulent K. pneumoniae isolate carrying and disseminating the blaKPC-2 gene highlights a severe threat to public health.
Introduction
Klebsiella pneumoniae is a major gram-negative pathogen for hospital-acquired infections in China (). One of its unique special populations, hypervirulent K. pneumoniae (hvKP) is associated with severe invasive infections in healthy individuals (), including pneumonia, genitourinary tract infection and septic shock (; ). In addition, carbapenem-resistant K. pneumoniae (CRKP), which is associated with high morbidity and mortality, commonly limits therapeutic strategies and causes poor prognosis. HvKP strains are generally susceptible to most of antibiotic drugs and belong to K1 or K2, while ST23 K. pneumoniae is classified as K1 and commonly considered to be hypervirulent (; ). In contrast, in CRKP groups, ST11 accounted for 63.9% of isolates in Zhejiang, China (). In previous studies, hypervirulent and carbapenem-resistant phenotypes were rarely observed to co-exist in single K. pneumoniae strain, but recent sporadic reports of carbapenem-resistant hypervirulent K. pneumoniae (CR-hvKP) signaled the emergence of this new superbug. The generation of such strains is achieved through virulence or drug-resistance gene transfer via plasmid dissemination such that ST11 CRKP acquired a highly virulent phenotype through a virulence plasmid and vice versa (; ). CR-hvKP is undoubtedly a superbug and its relative reports of which are increasing in frequency (). Thus, the occurrence and spread of CR-hvKP pose a considerable threat to public health and should be closely monitored.
Pseudomonas aeruginosa is another common nosocomial pathogen, and its carbapenem-resistance is intractable for clinical treatment, especially considering the intrinsic resistance of P. aeruginosa to many antibiotic classes. Notably, blaKPC-2-carrying plasmids have been detected in P. aeruginosa and can mediate carbapenem resistance (; ). Interspecies transmission of blaKPC-2-plasmids has been reported (; ) in CRKP, but no studies have demonstrated that plasmids mediate blaKPC-2 gene transfer between these two notorious pathogens. In our present study, we discovered a blaKPC-2-IncP1-plasmid that can conjugate from CR-hvKP to P. aeruginosa and have not been reported elsewhere previously. Obviously, the blaKPC-2 plasmid will present a major problem to public health and increase the difficulty of controlling epidemics caused by carbapenem-resistant strains. Here, we described an ST23 K. pneumoniae isolate, carrying the IncP1 KPC-2-encoding plasmid p27003_KPC. In addition, the novel plasmid could transmit blaKPC-2 from K. pneumoniae to P. aeruginosa.
Materials and Methods
Patient and Isolation Data
ZJ27003 was obtained from an elderly patient with chronic obstructive pulmonary disease (COPD). This isolate was identified using an automated Vitek 2 system (BioMérieux, Marcy l’Etoile, France). This study was approved by the Ethics Committees of the Sir Run Run Shaw Hospital (20170301-3) with a waiver of informed consent because of the retrospective nature of the study.
PCR and Sanger Sequencing
PCR and sequencing were used to screen the blaKPC-2 gene in ZJ27003 with the primers KPC-2-F (5′- ATGTCACTGTATCGCCGTCT -3′) and KPC-2-R (5′- TTTTCAGAGCCTTACTGCCC -3′).
Antimicrobial Susceptibility Testing
The minimum inhibitory concentration (MIC) values of imipenem, meropenem, ertapenem, ciprofloxacin, tetracycline, chloramphenicol, cefepime, cefotaxime, cefoxitin, cefuroxime and gentamicin were evaluated by the broth microdilution method, and those of amikacin, aztreonam, fosfomycin, ceftazidime/avibactam, tigecycline and colistin were determined according to the agar dilution method. The guidelines of the European Committee on Antimicrobial Susceptibility Testing (http://www.eucast.org/clinical_breakpoints) and Food and Drug Administration (https://www.fda.gov) were employed to estimate colistin and tigecycline resistance, while the others were confirmed by the Clinical and Laboratory Standards Institute 2020 guidelines.
String Test and Serum Killing Assay
The mucoviscous phenotype of this strain was estimated by stretching and evaluating a viscous string with an inoculation loop (positive, >5mm in length).
We collected fresh nonheated human serum (NHS) from 10 different healthy individuals and frozen the samples at -80°C. To ensure the accuracy of bacterial, we first calculated the cell concentration of bacterial suspension with an OD600 of 1, which was subsequently used for dilutions to make sure the final inocula concentration. In pre-experiments, we evaluated the bactericidal ability of the collected serum by incubating NTUH-K2044 and ATCC700603 (3×105 colony forming units, CFU) into 0.3 mL of serially diluted phosphate-buffered saline (PBS)-attenuated serum solutions. Based on our pilot results, we utilized 100% NHS to carry out subsequent experiments. To ascertain ZJ27003 human serum sensitivity, the isolate was shaken until reaching mid-log phase, and samples were inoculated at 3×105 CFU in 0.3mL 100% either pooled NHS or heat-inactivated human serum (HIS) for 3 h. HIS was produced through heating NHS at 56°C for 30 min. At one-hour intervals following inoculation, serially diluted bacteria were immediately plated on Mueller-Hinton agar. The serum bactericidal effect was presented as survival curves and rates, using the bacterial counts at each time point and the percentage survival values calculated when incubated with HIS were used as the denominator. In this assay, we used NTUH-K2044 as a hypervirulence control and ATCC700603 as a common strain control. This experiment was technically repeated three times.
Murine Infection Model
The virulence of the K. pneumoniae strain was evaluated using BALB/c female mice weighing 20-25 g (Ziyuan, Hangzhou, China). The hypervirulence and common strain controls were the same as those used in the serum killing assay. Briefly, overnight cultures were subcultured in fresh broth at a 1:1000 dilution until reaching mid-log phase, followed by diluting the adjusted bacterial suspension (OD600 = 1) to 5×107 with PBS. The mice were randomly placed into 3 groups, each of which had 10 mice. The grouped mice were intraperitoneally injected with 0.2 mL of prepared germ solution and observed and recorded every 12 h. The final result was visualized with GraphPad Prism. Animal protocols were approved by the Institutional Animal Ethics Committee of Zhejiang University with the number of ZJU20160154.
Whole Genome Sequencing (WGS) and Analysis
The total DNA of ZJ27003 was extracted and then sequenced on an Illumina-HiSeqTM 2000 sequencing system (Illumina Inc, San Diego, CA, USA) based on a paired-end 2×100 bp protocol and the single-molecule real-time technique via nanopore platform. Unicycler was utilized to de novo assemble the whole genome. Gene prediction and annotation were conducted on prokka. Chromosome maps were created by CGview (https://paulstothard.github.io/cgview/), and BRIG v0.95 was used to draw plasmid comparison profiles. The whole genome was submitted on the website of Center of the Genomics Epidemiology (http://www.genomicepidemiology.org/), in order to analyze its multilocus sequence type and resistance genes. Virulence genes were detected on Pasteur (https://bigsdb.pasteur.fr). Plasmid comparison results were acquired through BLAST (http://blast.ncbi.nlm.nih.gov). Similar published ST23 CR-hvKP strain information was obtained from BacWGST (http://bacdb.org/BacWGSTdb/Search_kpn.php). The genome sequence of strain ZJ27003 has been submitted to GenBank under the accession number CP067060-CP067062.
Conjugation
Since P. aeruginosa shows a high degree of natural resistance towards tigecycline, P. aeruginosa strain PAO1 was used as a recipient and ZJ27003 as a donor. The conjugation experiment followed the filter mating method. Mueller-Hinton agar containing tigecycline (8 mg/L) and meropenem (4 mg/L) was utilized to screen transconjugants. Transconjugant verification was performed by blaKPC-2 PCR and species identification with automated Vitek 2 system.
Results
Isolation of a Carbapenem-Resistant Strain
In February 2017, K. pneumoniae strain ZJ27003 was isolated from the sputum of an old patient who was diagnosed with COPD and hospitalized in the intensive care units of a tertiary hospital in Zhejiang, China. Drug susceptibility tests were performed and ZJ27003 showed carbapenem-resistance. The MICs was 16 mg/L for both imipenem and meropenem and reached at 32 mg/L for ertapenem (Table 1). Furthermore, ZJ27003 was resistant to aztreonam and cephalosporins.
Table 1
| Drug | Imipenem | Meropenem | Ertapenem | Ciprofloxacin | Tetracycline | Chloramphenicol | Cefepime | Cefotaxime | Cefoxitin |
|---|---|---|---|---|---|---|---|---|---|
| MICs | 16 | 16 | 32 | 0.016 | 1 | 4 | >32 | >8 | >64 |
| Drug | Cefuroxime | Ceftazidime | Gentamicin | C/A | Fosfomycin | Tigecycline | Colistin | Amikacin | Aztreonam |
| MICs | >64 | >32 | 1 | 2 | 16 | 0.5 | <0.125 | 2 | >64 |
MICs for ZJ27003 of carbapenems and other antibiotics(mg/L).
MICs, minimum inhibitory concentrations; C/A, ceftazidime/avibactam.
Genome Sequence Analysis
To determine the mechanism of ZJ27003 carbapenem resistance, we performed WGS and obtained a 5,428,398-bp circular chromosome and two plasmids (141,639 bp and 36,708 bp). A total of 5,187 putative open reading frames (ORFs) and 114 RNA genes were annotated on the chromosome, while 163 and 43 putative ORFs were carried on p27003_1 and p27003_KPC, respectively. General information on the chromosome and p27003_1 is shown in Supplementary Figure 1. Serotyping and multilocus sequence type analyses indicated that ZJ27003 belongs to serotype K1 and ST23. In addition, among the five identified drug resistance genes, fosA, blaSHV-190 and oqxAB were located on the chromosome (Supplementary Figure 1) and blaKPC-2 was carried by p27003_KPC (Figure 1).
Figure 1
An IncP1 blaKPC-2-Harboring Plasmid
p27003_KPC belongs to IncP1 and did not identify any existing plasmids on the GenBank database with high similarity and high coverage according to BLAST. Notably, a 20-kb backbone region in p27003_KPC is highly homologous to pICP-4GES (MH053445.1, comes from P. aeruginosa), with 99.98% identity, while the remaining components consist of a 6-kb blaKPC-2-embedded accessory region (excepted from p17ZR-91-IncFII-114, NZ_MN200129.1), which has been widely reported in K. pneumoniae blaKPC-2-plasmids.
Further exploration suggested that this integration was achieved by two IS26 elements (two green regions in Figure 1A). IS26 came from the K. pneumoniae blaKPC-2-containing translocatable unit, which duplicated itself and carried blaKPC-2 into the IncP1 plasmid. Additionally, the two IS26 elements interrupted Int1 and TrbB, and the remaining parts could completely map the flanked sequences of blaGES-5-surrounding regions on pICP-4GES (Figure 1B). Overall, IS26 helped blaKPC-2 and its accessary regions insert into the backbone of pICP-4GES and recombine a part of the antibiotic resistance gene out of the IncP1 plasmid.
p27003_KPC Spreading Between Species
Because the backbone of p27003_KPC was similar as a P. aeruginosa drug-resistant plasmid, we suspect that the recombinant plasmid could bring the carbapenem resistant phenotype into P. aeruginosa. Plasmid conjugation was proceeded between ZJ27003 and PAO1, a carbapenem-sensitive P. aeruginosa strain, and the recipient was named as PAO1-pKPC. The MIC values for PAO1-pKPC changed from 1 mg/L to 8 mg/L for both imipenem and meropenem (Table 2). In summary, P. aeruginosa can change to a carbapenem-resistant strain by acquiring p27003_KPC from K. pneumoniae.
Table 2
| Strains/Drugs | Imipenem | Meropenem |
|---|---|---|
| ZJ27003 | 16 | 16 |
| PAO1 | 1 | 1 |
| PAO1-pKPC | 8 | 8 |
MICs for ZJ27003, PAO1 and PAO1-pKPC of carbapenem antibiotics.
PAO1-pKPC, strain PAO1 with p27003_KPC.
CRKP ZJ27003 Virulence Genes and Virulence Assessment
Although ZJ27003 belongs to capsule type K1 and ST23, its string test is negative. Further analysis of the whole genome of ZJ27003 revealed 66 virulent-related genes. All virulence genes were harbored on the chromosome and concentrated in four large regions (Supplementary Figure 1). In addition, the lack of mucoid regulator gene rmpA/rmpA2 may explain the ZJ27003 non-hypermucoviscous phenotype. Moreover, ZJ27003 lacked aerobactin, which is thought to be tightly associated with K. pneumoniae virulence and serum-resistance. ZJ27003 exhibited an 80% survival rate at the point of three hours (Supplementary Figure 2), and the survival curves (Figure 2) were much closer to those of the hypervirulence control (NTUH-K2044) than the common strain control (ATCC700603). Similar result was noted in murine infection model. The survival rate in mice is significantly lower than ATCC700603 while comparable to the well-known hypervirulent strain NTUH-K2044 (Figure 3). Similar to other ST23 K. pneumoniae strains, ZJ27003 displayed a high serum-resistance and mouse infection manifestation.
Figure 2
Figure 3
Discussion
In this study, we identified an ST23 K. pneumoniae isolate ZJ27003 with an IncP1 blaKPC-2-harboring plasmid, p27003_KPC. The capsule type of this strain is K1 and it exhibits high human serum resistance and mouse infection manifestation. In addition, the negative string test matches the absence of the capsule regulatory gene rmpA/A2, which is considered interrelated with virulence (). This absence hints that hypermucoviscosity does not always co-occur with hypervirulence in K. pneumoniae (). In addition, all ZJ27003 virulence genes are carried on its chromosome and could be divide into the following functional categories: nutritional factors (allABCRS and ybbWY), toxins (clbABCDEFGHIJKLMNOPQR), iron uptake (fyuA, irp1, irp2 and ybtAEPQSTUX), biofilm formation (mrkABCDFHIJ), ferric iron transporter (kfuABC) and others (metabolism-related arc, fdrA, gcl, glxKR, TIM barrel protein hyi and unknown ylbEF). Surprisingly, of the four highly virulence-related siderophore systems (yersiniabactin, aerobactin, enterobactin and salmochelin), ZJ27003 carries only yersiniabactin, which commonly exists in all K. pneumoniae strains and unlikely to play a role in systemic infection (). In contrast, the hvKP-specific siderophores, salmochelin and aerobactin, are lacking in ZJ27003. Aerobactin is helpful for the survival of bacteria in human ascites and serum and mouse infection models (). However, ZJ27003 exhibited high serum resistance with aerobactin absence, which implied that other genes might contribute to serum survival ability. Additional hvKP strains and further research are needed to identify those genes.
Apart from carbapenem resistance, ZJ27003 shows aztreonam and cephalosporins resistance, which could be attributed to blaKPC-2 and blaSHV-190 (). In addition, for fosA and oqxAB carries limited resistance towards fosfomycin and fluoroquinolones (), ZJ27003 is sensitive to these two drugs.
Klebsiella pneumoniae carbapenemase (KPC) acts as the most prevalent carbapenemase in clinical K. pneumoniae isolates () and could also convey carbapenem-resistant phenotype in P. aeruginosa (), Salmonella () and other species. Its wide distribution is attributed to plasmid interspecies transmission ability. Considering that KPC seldom exists in ST23 K. pneumoniae (8/130 entries, BacWGST database), reports have not emerged that resistance gene carrying plasmids could conjugate among CR-hvKP and P. aeruginosa. Focusing on K. pneumoniae, the most prevalent carbapenemase-related plasmid replicon groups are IncF, A/C and X (), while IncP is rare but common in the strains from environment and exhibits a broad host range (). In 2015, Gang Li discovered a blaKPC-2 and fosA co-located IncP plasmid in a ST11 K. pneumoniae (), and IncP plasmid could also be duplicated in P. aeruginosa (). In other words, IncP group plasmids can be replicated, stabled and transcribed in both K. pneumoniae and P. aeruginosa. This group of plasmids might have the capacity to transfer and exchange between K. pneumoniae and P. aeruginosa. With this conjecture, we excluded the blaKPC-2-containing translocatable unit from p27003_KPC, and the coverage and identity were increased at 98% and 100% respectively, which hinted that the new plasmid might be a hybrid from pICP-4GES (a P. aeruginosa plasmid) and K. pneumoniae blaKPC-2-containing translocatable region. Conjugation experiments proved a part of our conjecture that the IncP1 plasmid could transfer from K. pneumoniae to P. aeruginosa.
According to the NCBI database, we found that the backbone of p27003_KPC is also highly similar to that of pDCT28, which is isolated from ocean sediment (). Additionally, this plasmid backbone exists in P. aeruginosa, Achromobacter xylosoxidans (KJ588780.1), Variovorax paradoxus () and Burkholderia ambifaria (). We further conjugate p27003_KPC into P. aeruginosa PAO1, and our experiment reveal that p27003_KPC can duplicate and multiply in P. aeruginosa and make recipients carbapenem-resistant. Based on this finding, we suspect p27003_KPC might directly bring blaKPC-2 into other species directly, which will lead to wider and easier dissemination of blaKPC-2.
Conclusion
In conclusion, we isolated the CR-hvKP strain ZJ27003 from an 85-year-old male. ZJ27003 is an ST23 K1 non-hypermucoviscous K. pneumoniae and exhibits high serum resistance and mouse infection manifestation. In addition, the carbapenem-resistant phenotype of this strain is mediated by the novel IncP1 blaKPC-2 plasmid p27003_KPC. This plasmid can conjugate from K. pneumoniae to P. aeruginosa. Notably, CR-hvKP carrying and disseminating blaKPC-2-harboring plasmids will pose a big challenge to public health.
Funding
This work was supported by the National Natural Science Foundation of China (grant No. 81672067, 81830069, and 81902102), the National Science and Technology major project (2018ZX10714002) and Zhejiang Province Medical and Health project (Grant No. 2019ZD023).
Statements
Data availability statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: NCBI Genbank; CP067060-CP067062.
Ethics statement
This study was approved by the 79 Ethics Committees of the Sir Run Run Shaw Hospital (20170301-3) with a waiver of informed consent because of the retrospective nature of the study.
Author contributions
YY, YJ, and JZ isolated and provided strain ZJ27003 and designed the study and experiments. RY and YL carried out the assays. YZ and PL analyzed the data. RY and SJ drafted and revised the manuscript. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2021.641830/full#supplementary-material
References
1
Bialek-DavenetS.CriscuoloA.AilloudF.PassetV.JonesL.Delannoy-VieillardA.-S.et al. (2014). Genomic Definition of Hypervirulent and Multidrug-ResistantKlebsiella pneumoniaeClonal Groups. Emerg. Infect. Dis.20 (11), 1812–1820. doi: 10.3201/eid2011.140206
2
BushK. (2013). Carbapenemases: Partners in Crime. J. Glob Antimicrob. Resist.1 (1), 7–16. doi: 10.1016/j.jgar.2013.01.005
3
ChangF. Y.ChouM. Y. (1995). Comparison of Pyogenic Liver Abscesses Caused by Klebsiella Pneumoniae and non-K. Pneumoniae Pathogens. J. Formosan Med. Assoc. = Taiwan yi zhi94 (5), 232–237.
4
ChavdaK. D.ChenL.FoutsD. E.SuttonG.BrinkacL.JenkinsS. G.et al. (2016). Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter Spp.: New Insights Into Phylogeny, Population Structure, and Resistance Mechanisms. mBio7 (6), e02093-16. doi: 10.1128/mBio.02093-16
5
ChenY. T.ChangH. Y.LaiY. C.PanC. C.TsaiS. F.PengH. L. (2004). Sequencing and Analysis of the Large Virulence Plasmid pLVPK of Klebsiella Pneumoniae CG43. Gene337, 189–198. doi: 10.1016/j.gene.2004.05.008
6
DaiX.ZhouD.XiongW.FengJ.LuoW.LuoG.et al. (2016). The IncP-6 Plasmid P10265-KPC From Pseudomonas Aeruginosa Carries a Novel DeltaISEc33-Associated Bla KPC-2 Gene Cluster. Front. Microbiol.7, 310. doi: 10.3389/fmicb.2016.00310
7
GalettiR.AndradeL. N.VaraniA. M.DariniA. L. C. (2019). A Phage-Like Plasmid Carrying Blakpc-2 Gene in Carbapenem-Resistant Pseudomonas Aeruginosa. Front. Microbiol.10, 572. doi: 10.3389/fmicb.2019.00572
8
GaoH.LiuY.WangR.WangQ.JinL.WangH. (2020). The Transferability and Evolution of NDM-1 and KPC-2 Co-Producing Klebsiella Pneumoniae From Clinical Settings. EBioMedicine51, 102599. doi: 10.1016/j.ebiom.2019.102599
9
HagemannJ. B.PfennigwerthN.GatermannS. G.von BaumH.EssigA. (2018). KPC-2 Carbapenemase-Producing Pseudomonas Aeruginosa Reaching Germany. J. Antimicrob. Chemother.73 (7), 1812–1814. doi: 10.1093/jac/dky105
10
HayesF.DangB.MaoD.LuoY. (2016). Complete Nucleotide Sequence of Incp-1β Plasmid Pdtc28 Reveals a Non-Functional Variant of the blaGES-Type Gene. PloS One11 (5), e0154975. doi: 10.1371/journal.pone.0154975
11
HuY.LiuC.ShenZ.ZhouH.CaoJ.ChenS.et al. (2020). Prevalence, Risk Factors and Molecular Epidemiology of Carbapenem-Resistant Klebsiella Pneumoniae in Patients From Zhejiang, Chin-2018. Emerg. Microbes Infect.9 (1), 1771–1779. doi: 10.1080/22221751.2020.1799721
12
JohnsonS. L.Bishop-LillyK. A.LadnerJ. T.DaligaultH. E.DavenportK. W.JaissleJ.et al. (2015). Complete Genome Sequences for 59 Burkholderia Isolates, Both Pathogenic and Near Neighbor. Genome Announc.3 (2), e00159-15. doi: 10.1128/genomeA.00159-15
13
KimS.CovingtonA.PamerE. G. (2017). The Intestinal Microbiota: Antibiotics, Colonization Resistance, and Enteric Pathogens. Immunol. Rev.279 (1), 90–105. doi: 10.1111/imr.12563
14
KopotsaK.Osei SekyereJ.MbelleN. M. (2019). Plasmid Evolution in Carbapenemase-Producing Enterobacteriaceae: A Review. Ann. N Y Acad. Sci.1457 (1), 61–91. doi: 10.1111/nyas.14223
15
LepuschitzS.SchillS.StoegerA.Pekard-AmenitschS.HuhulescuS.InreiterN.et al. (2019). Whole Genome Sequencing Reveals Resemblance Between ESBL-producing and Carbapenem Resistant Klebsiella Pneumoniae Isolates From Austrian Rivers and Clinical Isolates From Hospitals. Sci. Total Environ.662, 227–235. doi: 10.1016/j.scitotenv.2019.01.179
16
LiW.SunG.YuY.LiN.ChenM.JinR.et al. (2014). Increasing Occurrence of Antimicrobial-Resistant Hypervirulent (Hypermucoviscous) Klebsiella Pneumoniae Isolates in China. Clin. Infect. Dis.58 (2), 225–232. doi: 10.1093/cid/cit675
17
LiG.ZhangY.BiD.ShenP.AiF.LiuH.et al. (2015). First Report of a Clinical, Multidrug-Resistant Enterobacteriaceae Isolate Coharboring Fosfomycin Resistance Gene fosA3 and Carbapenemase Gene blaKPC-2 on the Same Transposon, Tn1721. Antimicrob. Agents Chemother.59 (1), 338–343. doi: 10.1128/AAC.03061-14
18
MiriagouV.TzouvelekisL. S.RossiterS.TzelepiE.AnguloF. J.WhichardJ. M. (2003). Imipenem Resistance in a Salmonella Clinical Strain Due to Plasmid-Mediated Class A Carbapenemase Kpc-2. Antimicrob. Agents Chemother.47 (4), 1297–1300. doi: 10.1128/aac.47.4.1297-1300.2003
19
PartridgeS. R.KwongS. M.FirthN.JensenS. O. (2018). Mobile Genetic Elements Associated With Antimicrobial Resistance. Clin. Microbiol. Rev.31 (4), e00088-17. doi: 10.1128/CMR.00088-17
20
QiY.WeiZ.LiL.JiS.DuX.ShenP.et al. (2010). Detection of a Common Plasmid Carrying blaKPC-2 in Enterobacteriaceae Isolates From Distinct Cities in China. Microb. Drug Resist.16 (4), 297–301. doi: 10.1089/mdr.2010.0023
21
RussoT. A.MarrC. M. (2019). Hypervirulent Klebsiella Pneumoniae. Clin. Microbiol. Rev.32 (3), e00001-19. doi: 10.1128/CMR.00001-19
22
RussoT. A.OlsonR.MacdonaldU.MetzgerD.MalteseL. M.DrakeE. J.et al. (2014). Aerobactin Mediates Virulence and Accounts for Increased Siderophore Production Under Iron-Limiting Conditions by Hypervirulent (Hypermucoviscous) Klebsiella Pneumoniae. Infect. Immun.82 (6), 2356–2367. doi: 10.1128/IAI.01667-13
23
ShonA. S.RussoT. A. (2012). Hypervirulent Klebsiella Pneumoniae: The Next Superbug? Future Microbiol.7 (6), 669–671. doi: 10.2217/fmb.12.43
24
TahmasebiH.DehbashiS.ArabestaniM. R. (2020). Prevalence and Molecular Typing of Colistin-Resistant Pseudomonas Aeruginosa (CRPA) Among beta-Lactamase-Producing Isolates: A Study Based on High-Resolution Melting Curve Analysis Method. Infect. Drug Resist.13, 2943–2955. doi: 10.2147/IDR.S264796
25
WalkerK. A.MillerV. L. (2020). The Intersection of Capsule Gene Expression, Hypermucoviscosity and Hypervirulence in Klebsiella Pneumoniae. Curr. Opin. Microbiol.54, 95–102. doi: 10.1016/j.mib.2020.01.006
26
WalkerK. A.MinerT. A.PalaciosM.TrzilovaD.FrederickD. R.BrobergC. A.et al. (2019). A Klebsiella Pneumoniae Regulatory Mutant Has Reduced Capsule Expression But Retains Hypermucoviscosity. mBio10 (2), e00089-19. doi: 10.1128/mBio.00089-19
27
WyresK. L.LamM. M. C.HoltK. E. (2020). Population Genomics of Klebsiella Pneumoniae. Nat. Rev. Microbiol.18 (6), 344–359. doi: 10.1038/s41579-019-0315-1
28
YaoB.XiaoX.WangF.ZhouL.ZhangX.ZhangJ. (2015). Clinical and Molecular Characteristics of Multi-Clone Carbapenem-Resistant Hypervirulent (Hypermucoviscous) Klebsiella Pneumoniae Isolates in a Tertiary Hospital in Beijing, China. Int. J. Infect. Dis.37, 107–112. doi: 10.1016/j.ijid.2015.06.023
29
ZhangM.BronsJ. K.van ElsasJ. D. (2016). The Complete Sequences and Ecological Roles of Two Incp-1β Plasmids, pHB44 and Pbs64, Isolated From the Mycosphere of Laccaria Proxima. Front. Microbiol.7, 909. doi: 10.3389/fmicb.2016.00909
Summary
Keywords
KPC-2, hypervirulent, K. pneumoniae, IncP1 plasmid, P. aeruginosa
Citation
Yan R, Lu Y, Zhu Y, Lan P, Jiang S, Lu J, Shen P, Yu Y, Zhou J and Jiang Y (2021) A Sequence Type 23 Hypervirulent Klebsiella pneumoniae Strain Presenting Carbapenem Resistance by Acquiring an IncP1 blaKPC-2 Plasmid. Front. Cell. Infect. Microbiol. 11:641830. doi: 10.3389/fcimb.2021.641830
Received
15 December 2020
Accepted
14 May 2021
Published
01 June 2021
Volume
11 - 2021
Edited by
Costas C. Papagiannitsis, University of Thessaly, Greece
Reviewed by
Rafael Coria Jimenez, National Institute of Pediatrics, Mexico; Sophia Vourli, University General Hospital Attikon, Greece
Updates
Copyright
© 2021 Yan, Lu, Zhu, Lan, Jiang, Lu, Shen, Yu, Zhou and Jiang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yan Jiang, jiangy@zju.edu.cn; Jiancang Zhou, jiancangzhou@zju.edu.cn
This article was submitted to Clinical Microbiology, a section of the journal Frontiers in Cellular and Infection Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.